Literature DB >> 28444770

Factors associated with local recurrence in operated osteosarcomas: A retrospective evaluation of 95 cases from a tertiary care center in a resource challenged environment.

Rishi R Poudel1, Vivek Tiwari1, Venkatesan S Kumar1, Sameer Bakhshi2, Shivanand Gamanagatti3, Shah Alam Khan1, Shishir Rastogi1.   

Abstract

BACKGROUND AND OBJECTIVES: Local control of disease is one of the main goals of osteosarcoma management. We conducted a retrospective evaluation of 95 operated cases of osteosarcoma over 7 years to know about the factors associated with local recurrence in resource-challenged environment of the developing world.
METHODS: The factors which were evaluated and compared between local recurrence and non-local recurrence groups included demographic profile, site of tumor, whether biopsy done outside, type of surgery (limb salvage or amputation), presence of pathological fracture, vicinity of neurovascular bundle, tumor volume, histological subtype, chemotherapy induced necrosis, surgical margins, and delay in surgery. The time to local recurrence after surgery was also noted in the local recurrence group.
RESULTS: At a mean follow-up of 2.8 years, biopsy done from outside the treating center and delay in surgery after completion of neo-adjuvant chemotherapy emerged as significant risk factors for local recurrence. Most of the local recurrences (80%) occurred within 12 months of the primary surgery.
CONCLUSIONS: Lack of financial resources and availability of few tertiary care centers dealing with musculoskeletal oncology in the developing countries, lead to overburden with a long waiting list for tumor surgery making the scenario different from the Western world.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  biopsy; delay in surgery; developing world

Mesh:

Year:  2017        PMID: 28444770     DOI: 10.1002/jso.24602

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  5 in total

1.  Biomaterials for Orthopaedic Diagnostics and Theranostics.

Authors:  Marian A Ackun-Farmmer; Clyde T Overby; Brittany E Haws; Regine Choe; Danielle S W Benoit
Journal:  Curr Opin Biomed Eng       Date:  2021-06-08

Review 2.  Changes in the Management of Malignant Bone Tumors in the COVID-19 Pandemic in Developing Countries.

Authors:  Vivek Tiwari; Pankaj Kumar Sharma; Venkatesan Sampath Kumar; Rishi R Poudel; Sanjay Meena; Roshan Banjara
Journal:  Cureus       Date:  2022-05-23

3.  Meta-analysis of the prognosis after surgical treatment of osteosarcoma complicated by pathologic fracture.

Authors:  Wei Zhong; Ziyi Wu; Yuhao Yuan; Wei Luo
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 3.940

4.  Treatment-Related Prognostic Factors in Managing Osteosarcoma around the Knee with Limb Salvage Surgery: A Lesson from a Long-Term Follow-Up Study.

Authors:  Jianping Hu; Chunlin Zhang; Kunpeng Zhu; Lei Zhang; Tao Cai; Taicheng Zhan; Xiong Luo
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

5.  Bone sarcoma surgery in times of COVID-19 pandemic lockdown-early experience from a tertiary centre in India.

Authors:  Venkatesan Sampath Kumar; Roshan Banjara; Sushma Thapa; Abdul Majeed; Love Kapoor; Ritvik Janardhanan; Sameer Bakhshi; Vijay Kumar; Rajesh Malhotra; Shah Alam Khan
Journal:  J Surg Oncol       Date:  2020-07-13       Impact factor: 3.454

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.